From the pntx2-6 toxin to the pnpp-19 engineered peptide: therapeutic potential in erectile dysfunction, nociception, and glaucoma

HIGHLIGHTS

  • who: PnTx and colleagues from the (CNR), Italy University of Su00e3o Paulo Ribeiru00e3o Preto have published the research: From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma, in the Journal: (JOURNAL)

SUMMARY

    Multiple pathways, in which the most important mediator is still nitric oxide (NO). PDE-5 inhibitor therapy fails in approximately 30-40% of men with ED (Goldstein et_al, 2012; Porst et_al, 2013; Simonsen et_al, 2016). While animal venoms are a miscellaneous of bioactive components with broad application following purification and isolation . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?